Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 12,580.70 +125.86 1.01%
S&P 500 1,332.42 +14.60 1.11%
Nasdaq 2,870.99 +33.46 1.18%
Ticker Volume Price Price Delta
STOXX 50 2,160.31 +12.39 0.58%
FTSE 100 5,391.14 +34.80 0.65%
DAX 6,396.84 +73.65 1.16%
Ticker Volume Price Price Delta
Nikkei 8,583.63 -73.45 -0.85%
TOPIX 720.05 -6.98 -0.96%
Hang Seng 18,897.10 -158.34 -0.83%
Gold 1,553.60 +0.17%
EUR-USD 1.2467 -0.2861%
Nasdaq 2,870.99 +1.18%
DJIA 12,580.70 +1.01%
S&P 500 1,332.42 +1.11%
FTSE 100 5,391.14 +0.65%
STOXX 50 2,160.31 +0.58%
DAX 6,396.84 +1.16%
Oil (WTI) 90.39 -0.41%
U.S. 10-year 1.724% -0.014
BAC:US 7.44 +4.06%
FB:US 28.84 -9.62%
  • Exchange: NASDAQ GM
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Medical-Drugs

Medivation Inc

Add to Portfolio

MDVN:US

86.6100 USD 0.7700 0.88%

As of 20:10:00 ET on 05/29/2012.

Snapshot for Medivation Inc (MDVN)

Open: 87.7100 Day's Range: 84.5400 - 88.9000 Volume: 480,935 Bid: 86.5900
Previous Close: 87.3800 52wk Range: 14.3200 - 89.4600 1-Yr Rtn: +263.14% Ask: 86.6100

Stock Chart for MDVN

No chart data available.
  • MDVN:US 86.6100
  • 1D
  • 1M
  • 1Y
87.3800
Interactive MDVN Chart

Previous Close

Key Statistics for MDVN

Current P/E Ratio (ttm) -
Estimated P/E (12/2012) -
Earnings Per Share (USD) (ttm) -0.8600
Est. EPS (USD) (12/2012) -0.7740
Est. PEG Ratio -
Market Cap (M USD) 3,139.67
Shares Outstanding (M) 36.25
Enterprise Value (M USD) (ttm) 2,947.04
Enterprise Value/EBITDA (ttm) -
Price/Book (mrq) 38.8019
Price/Sale (ttm) 37.2139
Dividend Indicated Gross Yield 0.0000
Next Earnings Announcement 08/09/2012
More MDVN Key Statistics mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Financials for MDVN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)
More MDVN Income Statement Data
  • Total Assets
  • Total Liabilities (M/USD)
  • Debt to Assets (%)
More MDVN Balance Sheet Data
  • Operating
  • Investing
  • Financing (M/USD)
More MDVN Cash Flow Data

Company Profile & Key Executives for MDVN

Medivation Inc. acquires, develops, and sells or partners biomedical technologies in the early development stage of the research and development process.

Kim D BlickenstaffChairmanDavid T HungPresident/CEO
C Patrick MachadoCFO/Chief Business Ofcr/SecyCheryl CohenChief Commercial Officer
More Company Profile & Key Executives for MDVN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Advertisements